2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Recurrence
2
Pancreatic Neoplasms
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Hematologic Neoplasms
2
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Metastatic Solid Tumors
1
Mesothelioma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hemorrhage
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Gynecological Solid Tumors
1
Fallopian Tube Neoplasms
1
Erectile Dysfunction
1
Diarrhea
1
Colitis
1
Childhood Solid Tumor
1
Carcinoma, Hepatocellular
1
Interventions
Octreotide
6
Irinotecan
6
Loperamide
5
Probiotics
3
Leucovorin
3
Fluorouracil
3
Fecal Microbiota Transplantation
3
Calcium Aluminosilicate
3
maltodextrin
2
telotristat ethyl
1
shosaiko-to
1
lanreotide
1
isatuximab
1
ceterizine hydrochloride
1
capivasertib
1
cabazitaxel
1
bile acid binding proteins
1
XRP6258
1
Theophylline
1
Temozolomide
1
Surveys and Questionnaires
1
Sulfasalazine
1
Sugars
1
Standard of Care
1
Raloxifene Hydrochloride
1
Radiation
1
Prednisone
1
PHY 906
1
Oxaliplatin
1
Long-Term Synaptic Depression
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diarrhea
×
Cell- and Tissue-Based Therapy
×
Clear all
NCT02814864
2021-08-03
PRISME
Assistance Publique - Hôpitaux de Paris
Phase 2
Unknown
12 enrolled